PortfoliosLab logo

Albireo Pharma, Inc. (ALBO)

Equity · Currency in USD · Last updated Sep 24, 2022

Company Info

ISINUS01345P1066
CUSIP01345P106
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$17.36
Year Range$16.32 - $37.29
EMA (50)$19.78
EMA (200)$24.17
Average Volume$384.76K
Market Capitalization$343.81M

ALBOShare Price Chart


Chart placeholderClick Calculate to get results

ALBOPerformance

The chart shows the growth of $10,000 invested in Albireo Pharma, Inc. in Jan 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $355 for a total return of roughly -96.45%. All prices are adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%AprilMayJuneJulyAugustSeptember
-39.11%
-19.28%
ALBO (Albireo Pharma, Inc.)
Benchmark (^GSPC)

ALBOReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-0.64%-10.55%
6M-38.75%-18.29%
YTD-19.58%-22.51%
1Y-41.03%-15.98%
5Y-3.38%8.10%
10Y-14.78%9.73%

ALBOMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202222.33%17.02%-10.53%6.67%-37.37%-0.35%4.68%-15.82%7.03%
2021-2.24%-4.94%1.12%-8.94%4.21%5.17%-18.68%6.78%2.13%-6.35%-17.90%-2.92%
2020-10.70%3.00%-29.98%37.20%19.15%-1.01%6.68%-1.56%19.95%-5.42%17.90%0.81%
20195.99%8.15%14.54%6.86%-4.42%-2.01%-19.70%-5.56%-18.20%-8.15%23.14%12.38%
201836.72%-3.43%-3.64%-6.14%2.49%13.31%-11.13%9.60%-4.68%-18.96%-0.97%-7.26%
201710.66%32.62%-7.76%-13.79%-1.01%0.59%19.51%0.49%-15.32%30.55%-8.52%2.32%
2016-27.32%36.55%-2.94%25.64%-17.49%-9.03%39.78%-0.71%0.02%40.86%44.07%-32.59%
201513.53%-9.93%-12.50%-3.36%0.87%-11.21%-1.94%-33.37%-34.62%-17.05%-3.29%-2.95%
201419.08%16.02%-13.33%-13.92%-9.36%1.41%-12.04%3.16%-14.80%-7.19%-2.58%-11.92%
201314.89%3.70%1.30%6.47%54.64%-10.49%17.46%-3.67%-33.40%-19.68%-11.46%1.79%
20121.59%2.47%-7.09%22.03%16.89%-23.36%14.73%0.34%0.00%-5.72%-11.43%-5.24%
201121.31%-8.56%3.45%6.19%-8.07%-8.78%-5.35%-29.94%-56.45%48.13%-17.49%-7.58%
2010-8.86%-0.50%7.02%5.39%9.33%-23.17%3.17%-4.62%42.47%-31.51%-53.17%7.65%

ALBOSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Albireo Pharma, Inc. Sharpe ratio is -0.62. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00AprilMayJuneJulyAugustSeptember
-0.62
-0.78
ALBO (Albireo Pharma, Inc.)
Benchmark (^GSPC)

ALBODividend History


Albireo Pharma, Inc. doesn't pay dividends

ALBODrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugustSeptember
-97.27%
-23.00%
ALBO (Albireo Pharma, Inc.)
Benchmark (^GSPC)

ALBOWorst Drawdowns

The table below shows the maximum drawdowns of the Albireo Pharma, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Albireo Pharma, Inc. is 98.99%, recorded on Dec 17, 2015. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.99%May 10, 20101413Dec 17, 2015
-34.52%Jan 12, 201019Feb 8, 201059May 4, 201078
-7.66%May 6, 20101May 6, 20101May 7, 20102
-3.64%Jan 5, 20101Jan 5, 20101Jan 6, 20102

ALBOVolatility Chart

Current Albireo Pharma, Inc. volatility is 73.73%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%AprilMayJuneJulyAugustSeptember
73.73%
23.28%
ALBO (Albireo Pharma, Inc.)
Benchmark (^GSPC)